Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Hypertension

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ajh/hpu151PMID 25156625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abstract 248: National Trends in Utilization and Economic Outcomes of Catheter Ablation for Atrial Fibrillation in the United States 2003-2008

  2014cited by this paper
• Resistant hypertension: demography and clinical characteristics in 6,292 patients in a primary health care setting.

  2014cited by this paper
• Demografía y características clínicas de la hipertensión resistente en 6.292 pacientes en atención primaria

  2014cited by this paper
• Faculty Opinions recommendation of A controlled trial of renal denervation for resistant hypertension.

  2014cited by this paper
• Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety

  2014cited by this paper
• Resistant hypertension—its identification and epidemiology

  2013cited by this paper
• Measuring, analyzing, and managing drug adherence in resistant hypertension.

  2013cited by this paper
• Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients.

  2013cited by this paper
• Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients

  2013cited by this paper
• Prevalence of Optimal Treatment Regimens in Patients With Apparent Treatment-Resistant Hypertension Based on Office Blood Pressure in a Community-Based Practice Network

  2013cited by this paper
• Resistant Hypertension

  2013cited by this paper
• Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients

  2012cited by this paper
• Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.

  2012cited by this paper
• Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.

  2012cited by this paper
• Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension.

  2012cited by this paper
• Resistant hypertension in visceral obesity.

  2012cited by this paper
• Prevalence of Hyperaldosteronism in Primary Care Patients with Resistant Hypertension

  2012cited by this paper
• [Frequency of hypertension resistant to treatment and indication for renal denervation].

  2012cited by this paper
• Resistant hypertension: incidence, prevalence, and prognosis.

  2012cited by this paper
• What is the prevalence of resistant hypertension in the United States?

  2012cited by this paper
• Resistant hypertension

  2012cited by this paper
• Refractory Hypertension: Definition, Prevalence, and Patient Characteristics

  2012cited by this paper
• Prevalence of resistant hypertension in non-elderly adults: prospective study in a clinical setting.

  2012cited by this paper
• PREVALENCE, CHARACTERISTICS AND PREDICTIVE VALUE OF SEVERE RESISTANT HYPERTENSION FOR THE INCIDENCE OF CARDIOVASCULAR DISEASE

  2012cited by this paper
• Prevalência de hipertensão resistente em adultos não idosos: estudo prospectivo em contexto ambulatorial

  2012cited by this paper
• Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk

  2012cited by this paper
• Description of Antihypertensive Use in Patients With Resistant Hypertension Prescribed Four or More Agents

  2011cited by this paper
• Prevalence of Resistant Hypertension in the United States, 2003–2008

  2011cited by this paper
• Under pressure: the search for the essential mechanisms of hypertension

  2011cited by this paper
• Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

  2011cited by this paper
• Prevalence of resistant hypertension in a general population in northern Italy: Associated cardiovascular risk factors and target organ damage

  2011cited by this paper
• Relation of central and brachial blood pressure to ECG left ventricular hypertrophy. The Czech post-MONICA study

  2011cited by this paper
• Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk

  2011cited by this paper
• Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.

  2009cited by this paper
• An uncertain future for cardiovascular drug development?

  2009cited by this paper
• Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

  2009cited by this paper
• [Association between refractory hypertension and cardiometabolic risk. The HIPERFRE study].

  2008cited by this paper
• Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.

  2008cited by this paper
• Asociación entre hipertensión refractaria y riesgo cardiometabólico. Estudio HIPERFRE.

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Characteristics of the patients referred to a Hypertension Unit between 1989 and 2003

  2008cited by this paper
• Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension.

  2005influential reference
• Resistant hypertension revisited: a comparison of two university-based cohorts.

  2005cited by this paper
• Demographic and clinical characteristics of hypertensive patients in the internal medicine outpatient clinic of a university hospital in Rio de Janeiro.

  2004cited by this paper
• Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.

  2004cited by this paper
• Value Trial: long-term blood pressure trends In 13449 patients with hypertension and high cardiovascular risk

  2004cited by this paper
• A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

  2003cited by this paper
• VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk.

  2003cited by this paper
• Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

  2002cited by this paper
• P-438: Relationship between obesity and resistant hypertension

  2002cited by this paper
• Is resistant hypertension really resistant?

  2001cited by this paper
• A006: Resistant hypertension in a tertiary care clinic: revisited

  2000cited by this paper
• Critical appraisal of the health research literature: prevalence or incidence of a health problem.

  1998cited by this paper
• White-coat resistant hypertension.

  1997cited by this paper
• Resistant hypertension in a tertiary care clinic.

  1991cited by this paper
• An introduction to meta-analysis.

  1989cited by this paper
• Prevalence of Drug Resistant Hypertension

  1988cited by this paper
• Original Papers

  1986cited by this paper

• The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)

  2026cites this paper
• Aprocitentan: a new horizon in the treatment of hypertension

  2025cites this paper
• Associations of insulin resistance surrogate with resistant hypertension and the severity of hypertension in the chronic kidney disease population

  2025cites this paper
• Renal Denervation for Hypertension: Current Evidence and Clinical Perspectives

  2025cites this paper
• Prevalence and determinants of apparent treatment-resistant hypertension among patients in South African primary care: a single-centre observational study

  2025influential citation
• Advances in Hypertension Management: Insights from the Latest European Guidelines

  2025cites this paper
• A study on the functional properties of bioactive peptides derived from snakehead fish (Channa striata)

  2025cites this paper
• Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review

  2025cites this paper
• Prevalence of apparent treatment-resistant hypertension and screening rates for primary aldosteronism in an asian ambulatory care setting

  2025cites this paper
• Physiologic profiling using plasma renin activity and aldosterone on blood pressure control among Ghanaian stroke survivors: A pilot trial

  2025cites this paper
• EPIDEMIOLOGIA DA HIPERTENSÃO ARTERIAL RESISTENTE EM UMA CIDADE DO SUL TOCANTINENSE

  2025cites this paper
• Revisiting Hypertension Treatment in Patients With Chronic Kidney Disease.

  2024cites this paper
• PREVALENCE, RISK FACTOR, MANAGEMENT AND OUTCOME OF RESISTANT HYPERTENSION: SYSTEMATIC REVIEW

  2024cites this paper
• siRNA as potential therapeutic strategy for hypertension.

  2024cites this paper
• Resistant hypertension: Diagnosis, evaluation, and treatment practical approach.

  2024cites this paper
• Association between Resistant Arterial Hypertension, Type 2 Diabetes, and Selected microRNAs

  2024cites this paper
• Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement

  2024cites this paper
• 2024 Clinical practice guidelines for Hypertension in adults

  2024cites this paper
• Predictive Factors of Apparent Treatment Resistant Hypertension Among Patients With Hypertension Identified Using Electronic Health Records

  2024cites this paper
• GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review

  2024cites this paper
• The Effects of Functional Training on the Ambulatory Blood Pressure and Physical Fitness of Resistant Hypertensive Elderly People: A Randomized Clinical Rehearsal with Preliminary Results

  2024cites this paper
• Long-term effect of obstructive sleep apnoea management on blood pressure in patients with resistant hypertension: the SARAH study

  2024cites this paper
• Zilebesiran: The First siRNA Drug Therapy for Hypertension

  2024cites this paper
• The Global Burden of Resistant Hypertension and Potential Treatment Options

  2024cites this paper
• Efficacy and Safety of Radiofrequency-Based Renal Denervation on Resistant Hypertensive Patients: A Systematic Review and Meta-analysis

  2024cites this paper
• Diagnosis and management of resistant hypertension

  2024cites this paper
• THE ALGORITHM FOR THE TREATMENT OF PATIENTS WITH TREATMENT-RESISTANT HYPERTENSION AT THE OUTPATIENT STAGE

  2023cites this paper
• The Changes of Cardiovascular Neurotransmitter Levels under Low-Intensity Focused Ultrasound Stimulation of the Vagus Nerve

  2023cites this paper
• Uncontrolled hypertension at the dentist: a case report of integrated healthcare

  2023cites this paper
• Prevalence of hypertension in Iran: An updated systematic review and meta-analysis of community-based studies

  2023cites this paper
• Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation

  2023cites this paper
• A review on nano-formulation of calcium channel inhibitors in treatment of hypertension

  2023cites this paper
• Hipertensión arterial refractaria al tratamiento. Definiciones y manejo actualizado

  2023cites this paper
• Advances in the Pathogenesis and Treatment of Resistant Hypertension

  2023cites this paper
• Stroke Is Associated with Refractory Hypertension among Resistant and Refractory Patients in a Cross-Sectional Study

  2023cites this paper
• Advanced echocardiography techniques (AETs) to assess left atrial structure and function in individuals with resistant hypertension

  2023cites this paper
• Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUIC

  2023cites this paper
• 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH).

  2023cites this paper
• Identification and characterization of the new generation sGC stimulator BAY 1165747 (BAY-747) designed for the treatment of resistant hypertension.

  2023cites this paper
• Genome‐wide Association Studies Categorized by Class of Antihypertensive Drugs Reveal Complex Pathogenesis of Hypertension with Drug Resistance

  2023cites this paper
• A new use of transcutaneous electrical nerve stimulation: Role of bioelectric technology in resistant hypertension (Review)

  2023cites this paper
• Gender Difference of Blood Pressure Control Rate and Clinical Prognosis in Patients With Resistant Hypertension: Real-World Observation Study

  2023cites this paper
• Novel Dual Endothelin Inhibitors in the Management of Resistant Hypertension

  2023cites this paper
• Compliance to Multidisciplinary Lifestyle Intervention Decreases Blood Pressure in Patients with Resistant Hypertension: A Cross-Sectional Pilot Study

  2023cites this paper
• Application of omics in hypertension and resistant hypertension

  2022cites this paper
• Treatment-resistant hypertension

  2022cites this paper
• The Burden of Resistant Hypertension Across the World

  2022cites this paper
• Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)

  2022cites this paper
• Naringin abrogates angiotensin-converting enzyme (ACE) activity and podocin signalling pathway in cobalt chloride-induced nephrotoxicity and hypertension

  2022cites this paper
• Prevalence and Associated Factors of Resistant Hypertension among Patients with Chronic Kidney Disease: An Example from Cameroon

  2022influential citation
• Effects of catheter‐based renal denervation on renin‐aldosterone system, catecholamines, and electrolytes: A systematic review and meta‐analysis

  2022cites this paper
• Resistant Hypertension in Patients With Type-2 Diabetes Mellitus: A Single-Center, Cross-Sectional Study

  2022cites this paper
• Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA

  2022cites this paper
• Efficacy of an mHealth App to Support Patients’ Self-Management of Hypertension: Randomized Controlled Trial

  2022cites this paper
• A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider

  2022cites this paper
• Role of α1‐blockers in the current management of hypertension

  2022cites this paper
• Back to Life Treatment of Resistant Hypertension- An Update

  2022cites this paper
• Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence

  2022cites this paper
• Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)

  2022cites this paper
• Metabolomics of Artichoke Bud Extract in Spontaneously Hypertensive Rats

  2021cites this paper
• Hypertension: Current trends and future perspectives

  2021cites this paper
• Efficacy and safety of Yangxue Qingnao granules for the treatment of essential hypertension

  2021cites this paper
• Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’

  2021cites this paper
• Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates

  2021influential citation
• Restless legs syndrome/Willis–Ekbom disease among patients with resistant hypertension versus stroke patients—a prospective study

  2021cites this paper
• Internet Use, Electronic Health Literacy, and Hypertension Control among the Elderly at an Urban Primary Care Center in Thailand: A Cross-Sectional Study

  2021cites this paper
• Targeting angiotensin type 2 receptors located on pressor neurons in the nucleus of the solitary tract to relieve hypertension in mice.

  2021cites this paper
• The Assessment of Resistant Hypertension-Related Cardiovascular Risk

  2021cites this paper
• Molecular Regulation of the RhoGAP GRAF3 and Its Capacity to Limit Blood Pressure In Vivo

  2020cites this paper
• Resistant Hypertension: Novel Insights.

  2020cites this paper
• Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

  2020cites this paper
• Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide.

  2020cites this paper
• Itaconimides derivatives induce relaxation in mesenteric artery and negative inotropism by inhibition of CA2+ influx

  2020cites this paper
• Optimizing Antihypertensive Medication Classification in Electronic Health Record-Based Data: Classification System Development and Methodological Comparison

  2020influential citation
• Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension

  2020cites this paper
• Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020

  2020cites this paper
• Treat-to-Target urate-lowering therapy in primary gout patients: A real-world retrospective study at a dedicated gout clinic in China

  2020cites this paper
• Aldosterone receptor antagonists.

  2020cites this paper
• Monte Carlo simulation of uncertainty to identify barriers to optimizing blood pressure control

  2020cites this paper
• Bariatric Surgery for Resistant Hypertension: Working in Progress!

  2020cites this paper
• Resistant Hypertension in People With CKD: A Review.

  2020cites this paper
• Resistant Hypertension: Where are We Now and Where Do We Go from Here?

  2020cites this paper
• Optimizing identification of resistant hypertension: Computable phenotype development and validation

  2020cites this paper
• Renal Denervation for Resistant Hypertension: Where Do We Stand?

  2020cites this paper
• Medication Non-adherence: a Major Cause of Resistant Hypertension

  2020cites this paper
• Role of the Carotid Body in an Ovine Model of Renovascular Hypertension

  2020cites this paper
• Is there any Hope for Monitoring Adherence in an Efficient and Feasible Way for Resistant Hypertension Diagnosis and Follow-Up?

  2020cites this paper
• Cuidados de enfermagem em pacientes com crise hipertensiva na Atenção Primária

  2020cites this paper
• Resistant hypertension, case based approach to diagnosis and management: case report

  2020cites this paper
• Antihypertensive activity of zein peptides extracted from creole corn (Zea mays L.) (blue and red) from the state of Mexico.

  2020cites this paper
• Трехлетняя динамика структурных показателей левого желудочка у больных с резистентной артериальной гипертензией на фоне четырехкомпонентной терапии

  2020cites this paper
• Resistant hypertension: focus on vascular lesions

  2020cites this paper
• Three-year dynamics of left ventricular structural parameters in patients with resistant arterial hypertension on four-component therapy

  2020cites this paper
• Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S ‐ releasing properties

  2020cites this paper
• Therapieresistente und ‑refraktäre Hypertonie

  2020cites this paper
• Brazilian Position Statement on Resistant Hypertension – 2020

  2020cites this paper
• Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.

  2019cites this paper
• Risk of resistant hypertension associated with restless legs syndrome and periodic limb movements during sleep: a study on 673 treated hypertensive individuals.

  2019cites this paper
• Renal sympathetic denervation for treatment of hypertension: where are we now in 2019?

  2019cites this paper
• Does treatment-resistant hypertension exist in children? A review of the evidence

  2019cites this paper